Skip to main content
. 2023 Oct 19;2(4):e143. doi: 10.1002/imt2.143

Figure 2.

Figure 2

Validation of two primer sets designed by multiPrime using two sequencing platforms. (A) Validation of the primer set on the ONT platform. MCS, mixed clinical specimens (2–4 clinical specimens in one tube); NC, negative control; stars indicate the target virus. (B) Validation of the primer set on the NextSeq. 500 platform. The primer set was designed by multiPrime (v2.0.3) with the following parameters: coordinate: 4; seq_number_ANI: 10; Others: Default. Clinical NC, normal clinical specimen, which refers to samples obtained from healthy individuals devoid of any viral sequences; NC, negative control refers to intentionally empty samples without any template; stars indicate the target virus.